Acadia Pharmaceuticals buy Morgan Stanley
Start price
19.12.23
/
50%
€27.40
Target price
19.12.24
€36.48
Performance (%)
-45.51%
Price
01.07.24
€14.93
Summary
This prediction is currently active. Massive losses of -45.51% have been the result for the BUY prediction by Morgan_Stanley. This prediction currently runs until 19.12.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | -2.386% | -2.386% |
iShares Core DAX® | 1.395% | -0.272% |
iShares Nasdaq 100 | 2.287% | 6.912% |
iShares Nikkei 225® | 1.617% | 3.038% |
iShares S&P 500 | 0.659% | 3.687% |
Comments by Morgan_Stanley for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $40.00 price target on the stock, up previously from $31.00.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Morgan_Stanley for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€17.30
18.03.24
18.03.24
€27.59
18.03.25
18.03.25
-13.70%
01.07.24
01.07.24